{
  "ptid_time": "130_S_4641_2012-04-04",
  "img_path": "/data/qiuhui/data/adni/images/130_S_4641/2012-04-04/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 63,257 mm³, 125.4% above the reference mean. With a Z-score of 2.87 (99.8th percentile), this represents significant enlargement; whole brain volume measures 1,061,230 mm³, 8.9% above the reference mean. With a Z-score of 1.12 (86.8th percentile), this represents mild enlargement; entorhinal cortex volume measures 3,202 mm³, 12.8% below the reference mean. With a Z-score of -0.79 (21.6th percentile), this represents normal volume ; fusiform gyrus volume measures 17,352 mm³, 2.0% above the reference mean. With a Z-score of 0.18 (57.2th percentile), this represents normal volume ; middle temporal gyrus volume measures 21,264 mm³, 10.9% above the reference mean. With a Z-score of 0.95 (82.9th percentile), this represents normal volume . ",
  "text_data": "Age is 73.6 years. Gender is Female. Education: 20 years. Handedness: Right. Race: White. Medical history: Psychiatric; Neurologic; Head, Eyes, Ears, Nose and Throat; Cardiovascular; Musculoskeletal; Renal-Genitourinary; Allergies or Drug Sensitivities; Major Surgical Procedures. MMSE: 26.0. MoCA: 23.0. Logical Memory: 5.0. APOEε4 alleles: 2.0. Biomarker levels: Florbetapir (AV45): 1.54 SUVR (profound elevated); Amyloid beta: 660.70 pg/mL (normal ); Total tau: 228.30 pg/mL (normal ); Phosphorylated tau: 21.43 pg/mL (normal ). ",
  "true_diagnosis": "Diagnosis: AD.",
  "gpt_diagnosis": "**Reasoning:** The data shows significant ventricular enlargement (Z-score 2.87) suggestive of brain atrophy, alongside normal Aβ, T-tau, and P-tau levels but profoundly elevated AV45 (amyloid PET), indicating amyloid pathology. Cognitive scores (MMSE 26, MoCA 23) are borderline, with APOE4 homozygosity increasing Alzheimer's risk.  \n**Diagnosis:** **Mild Cognitive Impairment (MCI)** (likely amyloid-positive, early Alzheimer's trajectory).  \n**Confidence:** **Medium** (confounded by normal CSF biomarkers but high amyloid PET and APOE4 risk).  \n\n*Note: AV45 elevation suggests amyloid deposition despite normal CSF Aβ, which can occur in early AD. Ventricular enlargement supports neurodegeneration, but preserved entorhinal cortex volume and borderline cognitive scores argue against full dementia.*",
  "timestamp": "2025-07-26T14:50:18.922871"
}